Answers are grounded in this paper and cite their sources.
Acetylcysteine seems to be beneficial in treating cystinuric stone-forming patients. It probably is effective in reducing cysteine to cystine disulfide, which is more soluble. Six brief case reports demonstrate its use and its lack of toxicity. The results merit a larger clinical trial.
No takes yet. Share an insight, caveat, or question.
Mulvaney et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: